Company profile: Kinneir Dufort
1.1 - Company Overview
Company description
- Provider of creative, technical and user experience expertise to define, create, develop and deliver products, including development of drug delivery devices (syringes, autoinjectors, inhalers), surgical devices, IVD platforms, therapeutic and wearable devices, and injectable devices, plus Sustainability Lab consulting, lifecycle assessments, design for circularity, materials assessment, sustainable manufacturing and packaging.
Products and services
- Diagnostic Product Development: Architects IVD-focused platforms by developing new instrumentation, engineering cartridges, optimizing system performance, and conducting market research to guide product requirements and usability
- Drug Delivery: Engineers wearable-class devices including large-volume wearables and develops prefilled syringes, autoinjectors, pen and patch injectors, inhalers, plus nasal and ocular delivery systems
- Surgical Devices: Develops minimally invasive systems involving robotic surgery tools, electrosurgical instruments, imaging and patient-positioning assemblies, and constructs wound care, closures, orthopaedic tools, and skincare therapy devices
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Kinneir Dufort
Hilbert Paradox
HQ: Belgium
Website
- Description: Provider of a digital health data management platform for doctors and other healthcare providers, enabling capture, storage, analysis, and correlation of data from wearable devices, apps, and other platforms. Also offers state-of-the-art mobile and web development services, including design, development, implementation, and maintenance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hilbert Paradox company profile →
TD2
HQ: United States
Website
- Description: Provider of oncology-focused contract research services, offering data-driven clinical study management for Phase I–III trials; preclinical tools with 400+ cancer models to maximize data value and predict patient response; regulatory support (IND readiness, development, filings, FDA interactions); PK/ADME assays; and CDX models including NCI-H1963 (lung) and CCRF-CEM (T-ALL) to accelerate translational oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TD2 company profile →
Artes Biotechnology
HQ: Germany
Website
- Description: Provider of biopharmaceutical production processes and CDMO services, including microbial cell line and process development, manufacturing of test and preclinical material, and vaccine development. Offers pre-developed recombinant protein processes (biosimilars, vaccines, enzymes), technology transfer and proprietary cell line licensing; supplies recombinant reagents from yeast and bacterial platforms; and develops yeast (Hansenula polymorpha) and E. coli systems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artes Biotechnology company profile →
Aragen Bioscience
HQ: United States
Website
- Description: Provider of preclinical contract research and development services specializing in recombinant cell line and hybridoma development, cell culture and protein purification process development and production, mammalian protein expression, primary and immortalized cell-based assays, in vivo models of human disease, custom immunological services, preclinical efficacy studies, and vivarium-based rodent studies including BSL-2 suites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aragen Bioscience company profile →
Dottikon ES
HQ: Switzerland
Website
- Description: Provider of chemicals, intermediates, and active pharmaceutical ingredients for chemical, biotech, and pharmaceutical industries; cGMP API manufacturing; process development (R&D, routefinding, process design); small-, pilot-, and large-scale production with expertise in hazardous reactions and high-potency products; project and quality management; recycling and waste treatment including thermal recovery and waste water treatment and purification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dottikon ES company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Kinneir Dufort
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Kinneir Dufort
2.2 - Growth funds investing in similar companies to Kinneir Dufort
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Kinneir Dufort
4.2 - Public trading comparable groups for Kinneir Dufort
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →